Comparative Pharmacology
Head-to-head clinical analysis: GRIFULVIN V versus HEAD SHOULDERS CONDITIONER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GRIFULVIN V versus HEAD SHOULDERS CONDITIONER.
GRIFULVIN V vs HEAD & SHOULDERS CONDITIONER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Binds to microtubule-associated proteins and disrupts fungal mitotic spindle formation, thereby inhibiting fungal cell division. It also interferes with fungal nucleic acid synthesis.
Not applicable; this is a cosmetic conditioner. No pharmacological mechanism.
500 mg orally once daily (non-microsize formulation) or 250 mg twice daily; typical duration is 4-8 weeks for tinea capitis, 2-6 weeks for tinea corporis, 4-6 weeks for tinea pedis.
Not applicable. Head & Shoulders Conditioner is a cosmetic product for external use on hair and scalp; no systemic dosing.
None Documented
None Documented
Terminal half-life: 9–24 hours. Clinical context: Steady-state achieved in 2–5 days; prolonged in hepatic impairment.
Not applicable for systemic elimination; local retention on hair/scalp lasts until next wash (typically 24-48 hours).
Renal (1% unchanged), fecal (33% as metabolites), biliary (minor). Extensive hepatic metabolism; <1% excreted unchanged in urine.
Renal (urine): <1% unchanged; biliary/fecal: <1% as parent compound; majority remains on hair/scalp and is removed via washing and shedding. Systemic absorption negligible.
Category C
Category C
Antifungal
Antifungal/Antidandruff